Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
2020 · The Lancet Oncology · 314 citations
https://doi.org/10.1016/s1470-2045(20)30224-2
M
M. Colledan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
452
Papers
8.5K
Citations
47
h-index
135
i10-index
M. Colledan is an academic researcher from Ospedale Papa Giovanni XXIII. The author has contributed to research in topics: Organ Transplantation Techniques and Outcomes & Liver Disease and Transplantation & Liver Disease Diagnosis and Treatment. The author has an h-index of 47, co-authored 385 publications.
ORCID: 0000-0002-3880-4763Papers by this author
worksEffect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
2021 · The Lancet Oncology · 282 citations
https://doi.org/10.1016/s1470-2045(21)00493-9
Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
2020 · Journal of Clinical Oncology · 222 citations
https://doi.org/10.1200/jco.20.01933
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
2010 · BMC Cancer · 159 citations
https://doi.org/10.1186/1471-2407-10-190
Delaying surgery for patients with a previous SARS-CoV-2 infection
2020 · British journal of surgery · 143 citations
https://doi.org/10.1002/bjs.12050
Hemolytic Uremic Syndrome: A Fatal Outcome after Kidney and Liver Transplantation Performed to Correct Factor H Gene Mutation
2005 · American Journal of Transplantation · 124 citations
https://doi.org/10.1111/j.1600-6143.2005.00783.x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat